| |
Change in Exercise Minutes (n = 40)
|
Change in Step Counts (n = 20)
|
|---|
|
Score Type
|
Pearson Correlation
|
p-value
|
Pearson Correlation
|
P-value
|
|---|
|
EORTC QLQ-C30
|
|
QLQ summary score
|
0.19
|
0.261
|
0.54
|
0.021
|
|
Global health status / QoL
|
0.03
|
0.865
|
−0.06
|
0.813
|
|
Physical functioning
|
0.09
|
0.589
|
0.24
|
0.344
|
|
Role functioning
|
0.32
|
0.044
|
0.60
|
0.007
|
|
Emotional functioning
|
0.08
|
0.638
|
0.54
|
0.016
|
|
Cognitive functioning
|
0.20
|
0.226
|
0.43
|
0.067
|
|
Social functioning
|
−0.11
|
0.504
|
0.29
|
0.232
|
|
Fatigue
|
−0.24
|
0.142
|
−0.42
|
0.074
|
|
Nausea and vomiting
|
−0.12
|
0.457
|
−0.46
|
0.046
|
|
Pain
|
0.03
|
0.846
|
−0.20
|
0.409
|
|
Dyspnoea
|
−0.22
|
0.172
|
−0.16
|
0.521
|
|
Insomnia
|
−0.08
|
0.616
|
−0.24
|
0.332
|
|
Appetite loss
|
−0.13
|
0.439
|
0.22
|
0.365
|
|
Constipation
|
0.10
|
0.547
|
−0.54
|
0.017
|
|
Diarrhoea
|
0.01
|
0.954
|
0.26
|
0.279
|
|
Financial difficulties
|
0.10
|
0.562
|
−0.08
|
0.758
|
|
MMRC Dyspnea Scale: Description of breathlessness
|
−0.07
|
0.683
|
−0.15
|
0.568
|
|
PHQ-9 Total Score (omits Q10)
|
−0.21
|
0.220
|
−0.01
|
0.962
|
- *Footnote: Quality of life and symptom questionnaires were collected at week 12. Readers should note that the Intervention Group (n = 20) had increased walking distance at week 6 (but not at week 12; see Table 2)
